Metropolis Healthcare acquires Kolhapur’s Ambika Pathology Laboratory

image credit- shutterstock

Metropolis Healthcare has announced the completion of its fourth acquisition in the last 10 months, with Dr. R.S. Patil’s Ambika Pathology Laboratory in Kolhapur joining the Metropolis network.

Founded and operated by Dr Rajendra Sadashiv Patil, the NABL-accredited facility is among the region’s leading diagnostic providers and has been acquired through a Business Transfer Agreement. This marks a key milestone in Metropolis’ “String of Pearls” strategy, which focuses on building strong regional clusters and expanding access to advanced diagnostics across India.

Established in 1995, Ambika Pathology Laboratory has built a strong reputation for quality, accuracy, and patient-centric care. The facility operates a central laboratory supported by 12 patient touchpoints and offers a comprehensive portfolio of tests. With nearly 75% of its revenue derived from B2C walk-in patients, Ambika has earned the trust of both patients and clinicians across Kolhapur and neighbouring towns. Its strong local connect makes it a strategic addition to Metropolis’ Western Maharashtra cluster, where the company already operates 19 laboratories across Pune, Kolhapur, Sangli, Satara, Solapur, Nashik, and Ahmednagar, supported by more than 200 patient service centres and a growing franchise network.

Commenting on the acquisition, Ameera Shah, Promoter and Executive Chairperson, Metropolis Healthcare Limited said: “Maharashtra continues to be a key growth market for Metropolis, contributing nearly 40% of our total revenues. The acquisition of Ambika Pathology further strengthens our Western Maharashtra cluster and supports our ambition to make high-quality diagnostics accessible to more communities."